Amer Sports Inc (AS) Stock News

PODCAST: Indonesia quake, Jason Arday dies, gas prices and Mount Etna  Reuters

AST SpaceMobile, a LEO satellite developer, trades at $74 per share with a $21.5B market cap despite a 127x price-to-sales ratio. The company justifies its valuation through partnerships with major telecom carriers covering 3B+ subscribers, a $1.3B backlog, and projected revenue growth to $1.76B by 2028. Analysts expect positive EBITDA in 2027, making the stock potentially attractive for long-term investors despite near-term volatility.

ASML, a Dutch semiconductor equipment manufacturer, ranks as the top company in The Motley Fool's Rule Breakers database with a Superscore of 99. The article explains David Gardner's 'Snap Cola' investment concept—identifying top dogs and first-movers in important emerging industries. ASML qualifies as it created the EUV lithography category and is the sole producer of these critical chip-making systems. The stock has returned over 200% since its 2020 recommendation and has been recommended three additional times, demonstrating the value of holding quality companies long-term.

TSMC and ASML are identified as two of the best long-term semiconductor stocks due to their dominant market positions. TSMC controls 73% of the foundry market and 90% of advanced AI chips, while ASML dominates with 90% market share in lithography and 100% in extreme ultraviolet equipment. The article recommends both stocks but slightly favors TSMC due to its lower valuation (36x earnings vs. ASML's 56x) and more diversified customer base.

ASML's stock dipped after reports that a Chinese government-backed company is manufacturing its own DUV lithography systems. While this could accelerate the decline of ASML's Chinese business (which has already fallen from 41% to 16% of revenue due to export restrictions), the company's growing EUV system sales for high-end AI chips outside China could offset losses. Long-term investors are advised to view the dip as a buying opportunity rather than a major threat.

PODCAST: Hormuz concessions, Typhoon Dolphin and Wisconsin's primary  Reuters

PODCAST: Israel rejects Gaza plan, Yemen Saudi strike and Taylor Swift  Reuters

A securities class action lawsuit has been filed against Erasca, Inc. and its executives for allegedly making false and misleading statements about its lead oncology drug candidate ERAS-0015. The company is accused of improperly comparing its drug to a competitor's candidate and failing to disclose patent and trade secret disputes. Investors who purchased Erasca stock between January 14, 2025 and April 26, 2026 must act by August 10, 2026 to serve as lead plaintiff.

AST SpaceMobile and Rocket Lab are pursuing different strategies in the satellite communications market. AST SpaceMobile focuses on connecting smartphones from orbit, while Rocket Lab is building a diversified space platform. The article examines which company's ability to convert ambitious networks into recurring cash flow will create more long-term value for investors.

The Rosen Law Firm is investigating potential securities claims against The Ensign Group, Inc. following a short seller report by Hunterbrook alleging the nursing home operator's business model relies on inadequate patient care, understaffing, and misuse of taxpayer funds. The allegations caused Ensign's stock to fall 8.15% on June 8, 2026. Investors who suffered losses are encouraged to join a prospective class action lawsuit.

Rosen Law Firm is investigating potential securities claims on behalf of Elauwit Connection, Inc. (NASDAQ: ELWT) shareholders. The company filed an 8-K on February 27, 2026, announcing non-reliance on previously issued interim financial statements due to an error in network construction project revenue recognition during the first nine months of 2025. The disclosure resulted in a 6.8% stock price decline to $7.12 per share on March 2, 2026. The firm is preparing a class action lawsuit seeking recovery of investor losses.

A class action lawsuit has been filed against Erasca, Inc. alleging that the company made false and misleading statements regarding its ERAS-0015 drug candidate. The lawsuit claims the preclinical data was based on improper comparisons and lacked reasonable basis. Following a patent infringement allegation from Revolution Medicines disclosed on April 28, 2026, Erasca's stock price declined approximately 48% from $19.15 to $9.90 per share. Investors have until August 10, 2026 to apply as lead plaintiff.

Hagens Berman is investigating securities fraud claims against Erasca, Inc. for allegedly misleading investors about its lead oncology drug ERAS-0015's competitive advantages, safety profile, and intellectual property protections. The company faces patent infringement allegations from Revolution Medicines and reported a patient death in clinical trials, triggering a $2.8 billion market capitalization loss. Investors with substantial losses can serve as lead plaintiffs with an August 10, 2026 deadline.

Kessler Topaz Meltzer & Check, LLP is investigating potential securities law violations by Medline Inc. following significant FDA violations related to manufacturing quality standards and microbial contamination. The company's stock fell over 7% after the FDA warning letter and dropped an additional 12% following disappointing Q2 results and lowered full-year guidance.

Klépierre, Europe's leading shopping mall operator, has raised its full-year 2026 guidance with EBITDA expected to reach a minimum of €1,150 million. The company demonstrated strong execution in a dynamic retail market, driving organic growth. As of July 31, 2026, the company had 286.86 million shares outstanding.

A class action lawsuit has been filed against EquipmentShare.Com Inc on behalf of investors who purchased stock during its IPO in January 2026 or through June 2026. The lawsuit was triggered by a June 24, 2026 report alleging undisclosed related party transactions that netted EquipmentShare founders at least $77 million. Following the report, the company's stock price fell 6.62% on June 24 and declined an additional 11.7% the next trading day.

Kaplan Fox & Kilsheimer LLP has filed class action lawsuits against PROCEPT BioRobotics Corporation for allegedly using undisclosed discount programs that artificially inflated handpiece unit sales and revenues during the Class Period (February 28, 2024 - February 25, 2026). The firm is also pursuing cases against Hub Group, Inc. and investigating potential securities violations at Alignment Healthcare, Inc. Investors with losses are encouraged to contact the firm before respective deadlines.

Kaplan Fox has filed a class action lawsuit against Hub Group, Inc. (NASDAQ: HUBG) on behalf of investors who purchased securities between April 28, 2023 and May 11, 2026. The company disclosed a $77 million accounting error in February 2026 involving understatement of purchased transportation costs, followed by a May 2026 announcement of additional material misstatements in 2023 and 2024 financial statements. Hub Group stock fell significantly following both disclosures.

Grabar Law Office has filed federal securities fraud class action investigations against four companies: Erasca for misleading statements about its ERAS-0015 drug candidate and undisclosed patent risks; Insulet for defective manufacturing controls leading to voluntary product corrections; Power Solutions for overstating sales demand and understating manufacturing costs; and PROCEPT BioRobotics for using undisclosed discount programs that artificially inflated sales and created excess inventory. Shareholders who purchased shares during specified periods are eligible to seek damages and corporate reforms.

AST SpaceMobile stock fell 33.6% in July following the announcement of a $1.15 billion convertible debt offering and a delay in its 45-satellite BlueBird constellation rollout from late 2026 to early 2027. While the company secured $3.8 billion in cash reserves providing 2-3 years of runway at current burn rates, the combination of debt dilution and missed operational milestones triggered immediate market sell-off, though a late-month analyst upgrade provided some recovery.

A class action lawsuit has been filed against Alarum Technologies Ltd (NASDAQ: ALAR) for allegedly making false and misleading statements regarding its subsidiary NetNut's illegal activity of linking customer home internet devices to networks without consent. The complaint alleges this activity facilitated cybercriminal operations and materially heightened the company's legal exposure. Investors who purchased Alarum securities between March 20, 2025 and July 2, 2026 can join the lawsuit, with a lead plaintiff deadline of October 5, 2026.

Klépierre, Europe's leading shopping mall operator, announced the release of its first-half 2026 financial report on August 6, 2026. The company raised its full-year 2026 guidance, projecting EBITDA to reach a minimum of €1,150 million, driven by strong execution in a dynamic retail market and organic growth.

Voiceover actor Eryn Andrews brings in more money from her side hustle than her full-time human performance engineering job at NASA. Here's how she got started.

PODCAST: Strait stakes  Reuters

Mowi ASA reported Q2 2026 harvest volumes across its global operations, with Norway leading at 85.0 thousand tonnes. The company announced a Share Purchase Agreement to divest its 9k GWT salmon farming operations in Canada East to Cooke Inc. for CAD 225 million on a debt-free basis.

Hub Group (NASDAQ: HUBG) is facing a securities class action lawsuit for allegedly making false and misleading statements about its financial reporting, including premature revenue recognition and understatement of transportation costs. The company revealed in February 2026 that it had understated costs by $77 million and later disclosed that 2023 and 2024 financial reports were also materially misstated. These disclosures resulted in stock drops totaling over $870 million in market capitalization. Investors who purchased shares between April 28, 2023, and May 11, 2026, can seek lead plaintiff status by August 28, 2026.

ARCpoint Inc. (TSXV: ARC) announced that the British Columbia Securities Commission issued a failure-to-file cease trade order on August 5, 2026, due to the company's failure to file audited annual financial statements for the year ended March 31, 2026, by the July 29 deadline. The cease trade order prohibits all trading in the company's Class A Subordinate Voting Shares. The delay stems from the company's lack of available funds to pay auditors and accounting personnel. Trading remains suspended until the company files the required documents and the BCSC revokes the order.

The Rosen Law Firm is investigating potential securities claims against The Ensign Group, Inc. following a short seller report by Hunterbrook alleging the nursing home operator's business model relies on inadequate patient care, understaffing, and misrouting of funds. Ensign's stock fell 8.15% on June 8, 2026, following the report's publication. The firm is preparing a class action lawsuit to recover investor losses.

A class action lawsuit has been filed against Blaize Holdings, Inc. (NASDAQ: BZAI) for allegedly making false and misleading statements regarding announced transactions, improper revenue recognition, and creating a false appearance of growth. The lawsuit covers investors who purchased securities between July 18, 2025 and April 28, 2026. The lead plaintiff application deadline is October 5, 2026.

ASML's share price has surged above $1,700, making it a candidate for a stock split. However, recent semiconductor sector weakness and ASML's high valuation (37x forward earnings) suggest a split is unlikely in 2026, with 2027 or 2028 being more probable. The company has not conducted a forward split since 2000.